22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review
Go back to 22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review| 22ND CENTURY GROUP, Inc. (NASDAQ: XXII) | Delayed: 4.78 +0.18 (3.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.60 | 52 Week High | $1.71 | |||
| Open | $4.65 | 52 Week Low | $0.71 | |||
| Day High | $4.89 | P/E | N/A | |||
| Day Low | $4.65 | EPS | $-0.60 | |||
| Volume | 33,720 | |||||
